Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study of the Risk of Bacteremia in Directed Cholangioscopic Examination of the CBD

NCT01673269 is registered in ClinicalTrials.gov with Texas Tech University Health Sciences Center, El Paso as lead sponsor.

NCT NCT01673269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01673269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study of the Risk of Bacteremia in Directed Cholangioscopic Examination of the CBD
Lead sponsor
Texas Tech University Health Sciences Center, El Paso
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2012
Completion date
October 31, 2013
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign stricture of common bile duct, cholangiocarcinoma, choledocholithiasis